ArticleAnnals of Indian Academy of Neurology2011
Treatment guidelines for Guillain-Barré Syndrome.
Article in Annals of Indian Academy of Neurology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
49 citing papers in PubMed, 94 citations in OpenAlex.
- Isolated Arterial Hypertension as a Rare Early Manifestation of Guillain-Barré Syndrome: A Case Report.Cureus · 2026Article
- Guillain-Barré Syndrome Presenting With Unilateral Facial Nerve Palsy: A Rare Presentation.Cureus · 2026Article
- Guillain-Barré Syndrome as the Initial Manifestation of Lyme Disease: Diagnostic Challenges.Cureus · 2026Article
- Article
- A structured rehabilitation program for functional recovery in Guillain-Barré syndrome: a case report.Journal of medical case reports · 2025Article
- Rehabilitation of a Pregnant Patient With Guillain-Barré Syndrome: A Physiotherapy Perspective.Cureus · 2025Article
- Evolving understanding of Guillain-Barré syndrome pathophysiology and the central role of the classical complement pathway in axonal injury.Frontiers in neurology · 2025Article
- Guillain-Barré Syndrome in Africa: Understanding, Addressing, and Empowering.Health science reports · 2024Article
- Article
- Article
- REFRACTORY GUILLAIN-BARRÉ SYNDROME IN A PATIENT WITH ASYMPTOMATIC MULTIPLE MYELOMA SUCCESSFULLY TREATED WITH LOW-DOSE RITUXIMAB.Acta clinica Croatica · 2023Article
- Guillain-Barre syndrome complicating knee infectious arthritis.Clinical case reports · 2023Article
- Guillain-Barré Syndrome Presenting as Painful Weakness and Edema of the Legs: A Case Report.Cureus · 2023Article
- Article
- Therapeutic Plasma Exchange in Certain Immune-Mediated Neurological Disorders: Focus on a Novel Nanomembrane-Based Technology.Biomedicines · 2023Review
- Carbohydrates: Binding Sites and Potential Drug Targets for Neural-Affecting Pathogens.Advances in neurobiology · 2023Article
- Heart Rate Variability: A Measure of Cardiovascular Health and Possible Therapeutic Target in Dysautonomic Mental and Neurological Disorders.Applied psychophysiology and biofeedback · 2022Review
- Course and Treatment of a Rare Neurological Sequelae After COVID-19: Miller Fisher Syndrome.Cureus · 2022Article
- Article
- Clinical predictors for mechanical ventilation and prognosis in patients with Guillian-Barre syndrome: a 10-year experience.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2021Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.